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Research into the immunopathogensis of chronic bacterial colonisation of cystic
ﬁbrosis (CF) patients has been hampered by lack of a suitable animal model. Whilst
models of chronic infection have been described, they rely on the use of artiﬁcial
embedding material to prevent rapid clearance of the bacteria. We hypothesised
that careful selection of the bacterial isolate, mouse strain and infection regime,
will result in a clinically relevant murine model of chronic S. aureus (SA) and
P. aeruginosa (PA) infection without the need for embedding materials. Previously
published models have largely used PA01 and lab attenuated SA strains. We have
screened several hundred clinical isolates of SA and PA and selected 5 strains of
each for murine infection experiments, based on genotype and phenotype. The
selected SA isolates include haemolytic strains from CF and non-CF sputum.
The PA isolates originated from CF or ICU patients and were selected based
on phenotype including ability to form bioﬁlm in vitro. Signiﬁcant differences
in the in vivo virulence of these strains have been shown. Equally essential is
mouse strain. C57BL6 mice are used almost exclusively, however this strain are
inherently resistant to bacterial infection. We have compared the survival and
colonisation of C57BL6, A/J, BALBc, Biozzi, FVB/N, NIH, SJL, CD1, MF1 and
NMRI female mice with PA and SA. Identifying a combination of mouse and
bacterial strain resulting in the prolonged survival of the animal whilst maintaining
chronic pulmonary infection, will allow investigation of the intricate immunological
and physiological disease processes involved during chronic pulmonary infection
of CF patients.
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In sputum of CF patients next to the aerobic bacteria also obligate anaerobic bacteria
exist. Similarly as in CF, patients with Chronic Obstructive Pulmonary Disease
(COPD) suffer from chronic infection and inﬂammation and produce large amounts
of sputum. Therefore, we investigated if also in the lungs of COPD patients obligate
anaerobes exist. 13 patients (5 female, 8 male, age 53−86 yrs, mean 69.8±10.3 yrs)
with COPD GOLD standard stage IV spontaneously expectorated one or more
sputum samples. Bacteria were identiﬁed using the Crystal® (Becton Dickinson,
Heidelberg, Germany), the Vitek® (BioMe´rieux, Marcy L’Etoile, France) and the
Rapid AnaII® (remel, Lenexa, KS, USA) identiﬁcation systems. Bacteria were
quantiﬁed using 10-fold dilutions, ﬁve different agar media, and an anaerobic
bench. Oxygen partial pressure (pO2) was measured in 4 sputum samples using an
oxygen electrode (MI-730, Microelectrodes Inc., Bedford, NH, U.S.A.). In all COPD
patients, at least one (maximum three) obligate anaerobic strain was identiﬁed.
The most frequently occurring species were Staphylococcus saccharolyticus (11×),
Peptostreptococcus prevotii (6×), Ps. anaerobius (3×), and Veillonella spp. (2×).
Ps. asaccharolyticus, Clostridium difﬁcile, and C. histolyticum were found once
each. All of these species have also been detected in CF sputum before. Bacterial
numbers ranged from 8×104 cfu/ml to 8×107 fu/ml. pO2 was slightly reduced to
16.7±2.5%. Compared to CF patients, the reduction of the pO2 in sputum of our
COPD patients is low. However, the presence of the same obligate anaerobic genera
and species in COPD and CF sputum stands in favour of a shared source of the
bacteria.
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Burkholderia multivorans and B. cenocepacia are the two most frequently acquired
species of Burkholderia cepacia complex (Bcc) in CF patients. This pathogen is
transmissible and very difﬁcult treat due to its antimicrobial resistance.
Objective: To identify the immunogenic outer membrane proteins (OMP) of
B. multivorans and B. cenocepacia using CF patient serum in order to aid the
design of prophylactic therapies.
Methods: The OMPs were isolated individually from two B. cenocepacia strains
and two B. multivorans strains, separated by 2-D electrophoresis and blotted onto
PVDF membranes. Immunogenic OMPs were detected by probing blots with serum
from CF patients colonised with Bcc followed by chemiluminescent detection.
Proteins spots were matched to corresponding spots on a Coomassie blue stained
gel, excised and subsequently identiﬁed by MALDI-TOF/MS.
Conclusions: Among the 140 immunogenic proteins identiﬁed from the four Bcc
strains, six of them were common to all strains, twelve were identiﬁed in both
B. multivorans strains and seven of them were identiﬁed in both B. cenocepacia
strains. The OMP Porin, OprM and chaperonin GroEl were all identiﬁed as being
considerably immunogenic in all strains.
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Burkholderia cepacia complex (Bcc) members are associated with patient mortality
in CF as they may induce ‘cepacia syndrome’, an acute deterioration of lung
function with associated septicaemia. Most Bcc species are multi-drug-resistant
and form bioﬁlms, further reducing their antibiotic susceptibility. To ascertain
whether Bcc bioﬁlm formation confers advantages to the pathogen by evading
host cell responses, we examined the interaction of neutrophils with Bcc bioﬁlms
in vitro. Confocal microscopy demonstrated that bioﬁlm formation protected Bcc
species from phagocytosis, illustrating that differentiated, neutrophil-like HL60 cells
(dHL60s) remain at the exterior surface of Bcc bioﬁlms >2h post-inoculation, im-
peding phagocytosis. Planktonic Bcc bacteria did form signiﬁcantly less bioﬁlm, up
to 72h after inoculation, when initially inoculated in tandem with dHL60s (p< 0.05);
however when added to bioﬁlms already established for 24−72h, dHL60s lead to an
increase in bioﬁlm density. Neutrophils undergo apoptosis and disintegrate shortly
after recruitment to the lung and repeat experiments demonstrated that whole-
cell lysates of dHL60 also increased the density of established bioﬁlms (48h).
Interestingly, dHL60s secreted signiﬁcant quantities of IL-8 <1h after contact with
Bcc bioﬁlm (p< 0.05), but degranulated less when added to older bioﬁlms (48−72h).
Hence, bioﬁlms facilitate Bcc species persistence in the CF lung and the presence
of neutrophils reinforces that bioﬁlm. Therefore, strategies to improve neutrophil
efﬁcacy in clearing colonising Bcc must focus on overcoming bioﬁlm-mediated
resistance.
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